CHICAGO (Reuters) - Using cervical fluid collected from routine Pap smears, U.S. researchers were able to spot genetic changes caused by both ovarian and endometrial cancers, offering promise for a ...

The eREACH study: A randomized study of an eHEALTH delivery alternative for cancer genetic testing for hereditary predisposition in patients with metastatic cancers.

Routine screenings have become a powerful tool in catching cervical cancer as early as possible. Now, research suggests the cervical cells collected during these exams could hold the key to efficient ...

Pap tests have long been used to detect cervical cancer early, but preliminary research suggests that cervical cells collected during those tests could also be used to catch other cancers, including ...

WASHINGTON (AP) — For years, doctors have lamented that there’s no Pap test for deadly ovarian cancer. Wednesday, scientists reported encouraging signs that one day, there might be. Researchers are ...

WASHINGTON — For years, doctors have lamented that there’s no Pap test for deadly ovarian cancer. On Wednesday, scientists reported a tantalizing hint that one day, there might be. Researchers ...